how big is Vital Chemtech?

As of Jun 06, Vital Chemtech Ltd has a market capitalization of 156.00 Cr, categorizing it as a Micro Cap company. There is no valid financial data available for the latest four quarters, but as of Mar'24, the Shareholder's Funds are 84.34 Cr and Total Assets are 137.45 Cr.

Market Cap: As of Jun 06, Vital Chemtech Ltd has a market capitalization of 156.00 Cr, which categorizes it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: There is no valid Consolidated or Standalone financial data available for the latest four quarters, including Net Sales and Net Profit.<BR><BR>Balance Sheet Snapshot: This is Consolidated data for the reporting period of Mar'24. The Shareholder's Funds are 84.34 Cr, and the Total Assets amount to 137.45 Cr.

Who are in the management team of Vital Chemtech?

As of March 2022, the management team of Vital Chemtech includes Vipul Jatashanker Bhatt (Chairman & Managing Director), Jay Vipul Bhatt and Sangeeta Vipul Bhatt (Whole-time Directors), Deepakkumar Kushalchandra Chaubisa and Hetalkumar Jayantilal Shah (Non-Executive & Independent Directors), and Puja Paras Mehta (Company Secretary).

As of March 2022, the management team of Vital Chemtech includes the following members:<BR><BR>1. Vipul Jatashanker Bhatt - Chairman & Managing Director<BR>2. Jay Vipul Bhatt - Whole-time Director<BR>3. Sangeeta Vipul Bhatt - Whole-time Director<BR>4. Deepakkumar Kushalchandra Chaubisa - Non-Executive & Independent Director<BR>5. Hetalkumar Jayantilal Shah - Non-Executive & Independent Director<BR>6. Puja Paras Mehta - Company Secretary<BR><BR>These individuals play key roles in the governance and management of the company.

When is the next results date for Vital Chemtech?

No Upcoming Board Meetings

Has Vital Chemtech declared dividend?

Vital Chemtech Ltd has declared a 5% dividend, amounting to 0.5 per share, with an ex-date of September 13, 2024. However, total returns over various periods show significant price declines, with limited contributions from dividends.

Vital Chemtech Ltd has declared a 5% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 5%<BR>- Amount per share: 0.5<BR>- Ex-date: 13 Sep 24<BR><BR>Dividend Yield: 0.77%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -15.14%, the dividend return was 0%, resulting in a total return of -15.14%.<BR><BR>Over the past year, the price return was -15.53%, with a dividend return of 0.67%, leading to a total return of -14.86%.<BR><BR>In the 2-year period, the price return was -43.94%, the dividend return was 0.93%, resulting in a total return of -43.01%.<BR><BR>For the 3-year period, there was no price return, no dividend return, and the total return was 0.0%.<BR><BR>In the 4-year period, the price return was 0%, the dividend return was 0%, and the total return was 0.0%.<BR><BR>Lastly, over the 5-year period, the price return was 0%, the dividend return was 0%, leading to a total return of 0.0%.<BR><BR>Overall, while Vital Chemtech has declared a dividend, the total returns over various periods indicate significant declines in price, with limited dividend contributions in the longer term.

What is the technical trend for Vital Chemtech?

As of May 5, 2025, Vital Chemtech's technical trend is mildly bearish, influenced by bearish moving averages and mixed signals from other indicators like the MACD and Bollinger Bands.

As of 5 May 2025, the technical trend for Vital Chemtech has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the daily moving averages remain bearish. The Bollinger Bands and KST are bearish on the weekly timeframe, and the OBV shows a mildly bearish trend. The RSI does not provide any signals on both weekly and monthly timeframes. Overall, the current technical stance is mildly bearish, driven primarily by the bearish moving averages and the mixed signals from other indicators.

Who are the peers of the Vital Chemtech?

Vital Chemtech's peers include Shri Ahimsa, Arvee Laboratories, Hindcon Chemical, Indian Emulsions, Jocil, Indian Phosphate, Paragon Fine, Par Drugs & Chemicals, and Mahickra Chem. In terms of performance, Mahickra Chem has the highest 1-year return at 23.91%, while Vital Chemtech has a return of -43.83%.

Peers: The peers of Vital Chemtech are Shri Ahimsa, Arvee Laborat., Hindcon Chemical, Indian Emuls, Jocil, Indian Phosphate, Paragon Fine, Par Drugs & Che., and Mahickra Chem.<BR><BR>Quality Snapshot: Excellent management risk is observed at Shri Ahimsa, Indian Phosphate, and Paragon Fine, while Average management risk is found at Arvee Laborat., Hindcon Chemical, Jocil, Vital Chemtech, Par Drugs & Che., and Mahickra Chem. Good growth is noted at Indian Emuls, while Below Average growth is present at Shri Ahimsa, Arvee Laborat., Hindcon Chemical, Jocil, Vital Chemtech, Indian Phosphate, Paragon Fine, Par Drugs & Che., and Mahickra Chem. Excellent capital structure is seen at Shri Ahimsa, Hindcon Chemical, and Par Drugs & Che., while Average capital structure is found at Vital Chemtech and the rest have Below Average capital structure.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Mahickra Chem. at 23.91%, while the peer with the lowest is Hindcon Chemical at -33.43%. Vital Chemtech's own 1-year return is -43.83%, which is lower than both. Additionally, several peers, including Hindcon Chemical, Indian Emuls, Paragon Fine, and Par Drugs & Che., have negative six-month returns.

What does Vital Chemtech do?

Vital Chemtech Ltd is a Micro Cap company in the Chemicals & Petrochemicals industry, incorporated in 2013 and converted to a Limited Liability Partnership in 2015. It has a market cap of INR 142 Cr, with no recent sales or profit data available.

Overview: <BR>Vital Chemtech Ltd operates in the Chemicals & Petrochemicals industry and is classified as a Micro Cap company.<BR><BR>History: <BR>Vital Chemtech Limited was originally incorporated as a Private Limited Company in 2013. It underwent a status change to a Limited Liability Partnership in 2015. There is no recent sales or profit data available.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: N/A <BR>Most recent Net Profit: N/A <BR>Market-cap value: INR 142 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 30.00 <BR>Industry P/E: 47 <BR>Dividend Yield: 0.84% <BR>Debt Equity: 0.14 <BR>Return on Equity: 5.16% <BR>Price to Book: 1.59<BR><BR>Contact Details: <BR>Address: Not available <BR>Phone: Not available <BR>Email: Not available <BR>Website: Not available

Who are the top shareholders of the Vital Chemtech?

The top shareholders of Vital Chemtech include promoter Vipul Bhatt, who holds 55.11% of the shares, with no pledged holdings. Other notable shareholders are three foreign institutional investors with 1.78% combined and Craft Emerging Market Fund Pcc- Elite Capital Fund, the highest public shareholder at 1.62%.

The top shareholders of Vital Chemtech include the promoters, with Vipul Bhatt being the largest individual shareholder, holding 55.11% of the company's shares. There are no pledged promoter holdings reported. In addition, the company has three foreign institutional investors (FIIs) holding a combined 1.78% of the shares. The highest public shareholder is Craft Emerging Market Fund Pcc- Elite Capital Fund, which holds 1.62%. Individual investors collectively own 20.82% of the shares.

How has been the historical performance of Vital Chemtech?

Vital Chemtech has experienced significant sales growth from 57.61 Cr in Mar'22 to 133.90 Cr in Mar'25, despite profitability challenges and fluctuating cash flows, including a loss in Mar'24. Total assets increased from 81.25 Cr to 181.64 Cr during the same period, indicating overall growth despite rising raw material costs.

Answer:<BR>The historical performance of Vital Chemtech shows significant fluctuations in key financial metrics over the past four years.<BR><BR>Breakdown:<BR>Vital Chemtech's net sales increased from 57.61 Cr in Mar'22 to 133.90 Cr in Mar'25, demonstrating strong growth, despite a dip to 98.27 Cr in Mar'24. Total operating income followed a similar trend, reaching 133.90 Cr in Mar'25 after a peak of 116.74 Cr in Mar'23. However, raw material costs surged from 38.11 Cr in Mar'22 to 107.39 Cr in Mar'25, impacting profitability. Operating profit (PBDIT) fluctuated, peaking at 14.92 Cr in Mar'23 but dropping to 13.35 Cr in Mar'25, while profit before tax saw a decline to 6.21 Cr in Mar'25 from 11.48 Cr in Mar'23. The profit after tax also reflected this volatility, with a loss of 1.30 Cr in Mar'24 turning into a profit of 4.06 Cr in Mar'25. The total assets of the company increased significantly from 81.25 Cr in Mar'22 to 181.64 Cr in Mar'25, alongside total liabilities rising from 81.25 Cr to 181.64 Cr in the same period. Cash flow from operating activities improved to 6.00 Cr in Mar'25, although the net cash inflow remained at 0.00 Cr, indicating challenges in cash management. Overall, while Vital Chemtech has shown growth in sales and assets, it has faced profitability challenges and fluctuating cash flows.

Is Vital Chemtech overvalued or undervalued?

As of November 18, 2025, Vital Chemtech is considered very expensive and overvalued with a PE Ratio of 30.13, despite being lower than some peers, as it has underperformed significantly with a year-to-date return of -22.02% compared to the Sensex's gain of 9.58%.

As of 18 November 2025, the valuation grade for Vital Chemtech has moved from attractive to very expensive, indicating a significant shift in its market positioning. The company is currently considered overvalued based on its financial metrics. Key ratios include a PE Ratio of 30.13, an EV to EBITDA of 19.72, and a Price to Book Value of 1.47, all of which suggest a premium valuation compared to industry norms.<BR><BR>In comparison to its peers, Vital Chemtech's PE Ratio is notably lower than that of Solar Industries at 94.24 and Gujarat Fluoroch at 57.77, but still higher than Godrej Industries, which is rated attractive with a PE of 37.03. The company's recent stock performance has been poor, with a year-to-date return of -22.02%, significantly underperforming the Sensex's gain of 9.58% during the same period, reinforcing the notion that the stock may be overvalued in the current market context.

Why is Vital Chemtech falling/rising?

As of 14-Dec, Vital Chemtech Ltd's stock price is at 56.00, reflecting a significant decline of 25.03% year-to-date and a 60.13% drop over the past three years, underperforming the Sensex. The stock is also trading below its moving averages, indicating a bearish trend and reduced investor interest.

As of 14-Dec, Vital Chemtech Ltd's stock price is falling, currently at 56.00, which reflects a decrease of 0.9 or 1.58%. The stock has underperformed compared to the benchmark Sensex, with a performance today that is 1.64% lower than its sector. Over the past week, the stock has declined by 6.98%, while the Sensex has only fallen by 0.53%. <BR><BR>Additionally, the stock has shown a significant decline year-to-date, down 25.03%, compared to a 10.16% increase in the Sensex. The longer-term performance is also concerning, with a 60.13% drop over the past three years, while the Sensex has gained 40.82% in the same period. <BR><BR>Vital Chemtech is trading below its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a bearish trend. Furthermore, there has been a notable decrease in investor participation, with delivery volume on 11 Dec falling by 23.08% against the 5-day average. This decline in trading activity suggests reduced interest in the stock, contributing to its downward price movement.

Which are the latest news on Vital Chemtech?